Ramesh Kumar, Ph.D. is listed as an executive officer and director on 8 SEC Form D filings by 1 issuer between May 2009 and Oct 2015: Traws Pharma, Inc. (Newtown, PA — biotechnology — 2009–2015; $50M reported sold to 67 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Ramesh Kumar, Ph.D. and found 8 differences: Bankruptcy case: NEW YORK CITY SHOES,INC. v. MANIAR COLLECTION A DIVISION OF MANN IMPORT; Form D filed 17 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.